Valuation: Duality Biotherapeutics, Inc.

Market Cap 14.46B 16.82B 2.14B 1.85B 1.74B 1.58B 2.97B 205B 3.02B 20.36B 7.98B 103B 8.05B 7.88B 342B P/E 2026 *
-28.3x
P/E 2027 * -27.1x
Enterprise Value 14.68B 17.08B 2.18B 1.88B 1.76B 1.61B 3.02B 208B 3.06B 20.67B 8.1B 104B 8.17B 8B 347B EV / Sales 2026 *
9.51x
EV / Sales 2027 * 10.3x
Free-Float
80.75%
Yield 2026 *
-
Yield 2027 * -
1 day-3.43%
1 week-3.93%
Current month+2.31%
1 month-21.59%
3 months-18.85%
6 months-45.77%
Current year-37.63%
1 week 180.2
Extreme 180.2
213.8
1 month 164.9
Extreme 164.9
247
Current year 158.5
Extreme 158.5
376.8
1 year 158.5
Extreme 158.5
563.5
3 years 158.5
Extreme 158.5
563.5
5 years 158.5
Extreme 158.5
563.5
10 years 158.5
Extreme 158.5
563.5
Manager TitleAgeSince
Chief Executive Officer 56 2019-07-02
Director of Finance/CFO 40 2026-03-22
Chief Tech/Sci/R&D Officer - 2025-04-06
Director TitleAgeSince
Chairman 56 2019-07-02
Director/Board Member 45 2026-03-22
Director/Board Member 40 2021-04-22
Date Insider Type Main position Quantity % Market Cap.
1/16/26 Other

Chief Financial Officer

150,000 0.1678%
1/12/26 Other

Head of Human Resources

100,000 0.1119%
12/17/25 Other 20,800 0.0236%
Change 5-day change 1-year change 3-year change Capi.($)
-3.43%-3.93%-48.04% - 2.22B
+0.30%+2.75%+38.86%+1.08% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-3.45%+11.90%+164.29% 46.87B
-1.39%+1.82%-50.22%-50.44% 46.34B
-0.32%+0.58%+50.90%-21.15% 31B
+1.80%+8.94%+130.05%-34.84% 25.28B
+2.78%+2.44%+42.08%+90.79% 24.36B
+1.65%+0.53%-2.21%+190.26% 20.81B
+3.95%+1.02%+67.20%+117.59% 16.08B
Average +0.58%+0.27%+23.80%+54.05% 34.38B
Weighted average by Cap. +0.49%+0.52%+23.38%+39.34%

Financials

2026 *2027 *
Net sales 1.54B 1.8B 229M 198M 185M 169M 317M 21.88B 322M 2.17B 851M 10.96B 859M 841M 36.47B 1.47B 1.71B 218M 188M 177M 161M 303M 20.87B 307M 2.07B 812M 10.46B 819M 802M 34.78B
Net income -410M -478M -60.89M -52.57M -49.32M -44.92M -84.47M -5.82B -85.64M -578M -227M -2.92B -229M -224M -9.7B -484M -563M -71.81M -61.99M -58.16M -52.97M -99.6M -6.87B -101M -682M -267M -3.44B -270M -264M -11.44B
Net Debt 219M 254M 32.43M 28M 26.27M 23.92M 44.99M 3.1B 45.61M 308M 121M 1.55B 122M 119M 5.17B 689M 801M 102M 88.18M 82.73M 75.35M 142M 9.77B 144M 970M 380M 4.89B 383M 375M 16.28B
Logo Duality Biotherapeutics, Inc.
Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.
Employees
-
Date Price Change Volume
26-08-17 HK$186.00 -3.43% 1,177,941
26-08-14 HK$192.60 +0.31% 747,062
26-08-13 HK$192.00 -1.49% 771,059
26-08-12 HK$194.90 -2.21% 525,654
26-08-11 HK$199.30 +2.15% 1,544,026
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
159.82CNY
Average target price
363.65CNY
Spread / Average Target
+127.53%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9606 Stock